LIVE MARKETS-European shares set for weekly loss
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com.
EUROPEAN SHARES SET FOR WEEKLY LOSS
European equities eased on Friday and were set for a weekly loss, as investors digested mixed batch of quarterly results and awaited key euro zone inflation figures. The pan-European STOXX 600 index .STOXX is still heading for a monthly gain, but was down 0.4% on Friday, having hit record highs on Wednesday, as traders weighed the chances of fewer interest rate cuts in the U.S. and Europe, a flurry of earnings results and a fragile Sino-U.S. trade truce.
Attention will turn to euro zone inflation data due this morning after the European Central Bank kept interest rates unchanged at 2% on Thursday for the third meeting in a row, flagging a more resilient economy.
Shares in French reinsurer SCOR SCOR.PA fall 6.5% following what JPMorgan analysts deem "not (its) best quarter".
(Joice Alves)
EARLIER ON LIVE/ MARKETS:
BEFORE THE BELL: FUTURES STEADY BUT ANOTHER MONTH OF GAINS CLICK HERE
NO TRICKS, SOME TREATS FOR MARKETS CLICK HERE
Related Articles
Tesla’s 2025 Shareholder Meeting Showdown: Musk’s Leadership and Tesla’s Crossroads
TradingKey - Tesla (TSLA), the electric vehicle leader, will hold its 2025 Annual Shareholder Meeting on November 6. Dubbed by CEO Elon Musk as a moment that will “decide Tesla’s future and shape the world’s,” the event centers on one pivotal question: Will shareholders approve Musk’s proposed $1 T
What Drove the 'Black Tuesday' Sell-Off? Three Key Factors Behind the U.S. Stock Plunge
TradingKey - On November 4, 2025, U.S. markets suffered a sudden and sharp selloff — dubbed “Black Tuesday” — with the Nasdaq posting its largest single-day drop in a month. The rout unfolded amid growing economic and political instability, as a record-long government shutdown worsened systemic
IonQ Stock Price Skyrockets 300% in a Year, But Recently Drops 30%—Is IonQ Still a Buy?
Is IonQ worth buying? With a recent decline of nearly 30% over the past month, is now the time to buy? How much further could IonQ's stock rise?
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.
Palantir Q3 2025 Earnings: Blowout Performance Can’t Hide an AI Bubble， Four Growing Risks Behind a Nearly 1,000x Valuation
TradingKey – After the close of trading on November 4, “AI application King” Palantir Technologies (PLTR) reported its third-quarter earnings for fiscal year 2025. Despite a blowout quarter, surging top-line growth, and a flood of commercial orders, the stock plunged in after-hours trading.
